Market Alert: Ceasefire Hopes Between Israel and Iran Falter, Renewing Market Volatility
Pro Medicus Limited (ASX: PME) has secured an AU$170 million, 10-year contract through its U.S. subsidiary, Visage Imaging, with Colorado-based UCHealth, a leading health system comprising 14 hospitals across Colorado, Wyoming, and western Nebraska.
The platform will be fully cloud-based, in line with Visage’s CloudPACS strategy, and seamlessly integrated with UCHealth’s electronic health records. Implementation will begin immediately, with go-live targeted for Q2 of calendar year 2026. This transaction-based contract underscores Visage’s accelerating momentum in the North American healthcare IT market. CEO Dr Sam Hupert emphasised the growing adoption of unified, cloud-native imaging solutions, with cardiology integration marking a strategic expansion. Pro Medicus continues to strengthen its market position, driven by increasing demand for its comprehensive “full stack” imaging platform.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Jul 03, 2025
Jul 03, 2025
Jul 03, 2025
Jul 03, 2025
Jul 03, 2025
Jul 03, 2025
Jul 03, 2025
Jul 03, 2025
Jul 02, 2025
Jul 02, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.